Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/EBIT

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 9.7111.3063.7525.3716.03

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 9.71 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37
Mar202016.03

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37
58.27
Mar2020 16.03 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹13,813.1 Cr -4.4% -6.2% -22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,188.0 Cr -1.5% 4.6% 3% Stock Analytics
DIVIS LABORATORIES ₹143,074.0 Cr -4.8% -3.2% 40.7% Stock Analytics
CIPLA ₹115,768.0 Cr -1.3% -1.9% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,809.0 Cr 1.1% 6.1% 27.1% Stock Analytics
DR REDDYS LABORATORIES ₹92,503.5 Cr -3.6% -2.7% -11.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.4%

-6.2%

-22.9%

SENSEX

-2.4%

0.7%

0.5%


You may also like the below Video Courses